New findings by the Ratnayaka group has shown how the Alzheimer’s-linked amyloid beta (Ab) proteins that collect in the ageing retina can contribute to sight-loss. This study provides new insights into how the retina can become damaged in age-related macular degeneration. Anti-Ab treatments can therefore be tested in the future, which may prove useful in preventing retinal damage by these toxic molecules. The study was funded by the NC3Rs and published in the journal Cells. Huge congratulations to Dr Savannah Lynn on this excellent result and to everyone named on the publication.
